Skip to content
10-Q

Quarterly Report

VYCOR MEDICAL, INC. VYCO

0001493152-25-022771

← back to feed
Filed
Nov 14, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 14, 2025 33.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 33.37M sh
Shares Diluted Q3 2025 · Sep 30, 2025 33.37M sh
Shares Diluted Q3 2025 · Sep 30, 2024 32.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 32.72M sh
Capex Q3 2025 · Sep 30, 2025 $3.62K
Capex restated Q3 2025 · Sep 30, 2024 $5.37K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$52.7K
Operating Cash Flow Q3 2025 · Sep 30, 2024 $98.39K
Cash And Equivalents Q3 2025 · Sep 30, 2025 $64.23K
Cash And Equivalents Q3 2025 · Dec 31, 2024 $105.65K
Stockholders Equity Q3 2025 · Sep 30, 2025 −$4.02M
Stockholders Equity Q3 2025 · Jun 30, 2025 −$3.87M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$3.69M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$3.68M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$3.53M
Stockholders Equity Q3 2025 · Dec 31, 2023 −$3.33M
Current Liabilities Q3 2025 · Sep 30, 2025 $4.82M
Current Liabilities Q3 2025 · Dec 31, 2024 $4.5M
Total Liabilities Q3 2025 · Sep 30, 2025 $4.97M
Total Liabilities Q3 2025 · Dec 31, 2024 $4.69M
Current Assets Q3 2025 · Sep 30, 2025 $662.6K
Current Assets Q3 2025 · Dec 31, 2024 $632.98K
Total Assets Q3 2025 · Sep 30, 2025 $941.2K
Total Assets Q3 2025 · Dec 31, 2024 $998.12K
Eps Diluted Q3 2025 · Sep 30, 2025 $0.00
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.01
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.01
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.01
Eps Basic Q3 2025 · Sep 30, 2025 $0.00
Eps Basic Q3 2025 · Sep 30, 2025 −$0.01
Eps Basic Q3 2025 · Sep 30, 2024 −$0.01
Eps Basic Q3 2025 · Sep 30, 2024 −$0.01
Sga Expense Q3 2025 · Sep 30, 2025 $404.97K
Sga Expense Q3 2025 · Sep 30, 2025 $1.1M
Sga Expense Q3 2025 · Sep 30, 2024 $367.89K
Sga Expense Q3 2025 · Sep 30, 2024 $1M
Rd Expense Q3 2025 · Sep 30, 2025 $9.96K
Rd Expense Q3 2025 · Sep 30, 2024 $6.43K
Rd Expense Q3 2025 · Sep 30, 2024 $8.69K
Net Income Q3 2025 · Sep 30, 2025 $4.94K
Net Income Q3 2025 · Sep 30, 2025 −$9.74K
Net Income Q3 2025 · Sep 30, 2024 −$59.82K
Net Income Q3 2025 · Sep 30, 2024 −$100.46K
Operating Income Q3 2025 · Sep 30, 2025 $32.09K
Operating Income Q3 2025 · Sep 30, 2025 $70.43K
Operating Income Q3 2025 · Sep 30, 2024 −$35.14K
Operating Income Q3 2025 · Sep 30, 2024 −$28.49K
Gross Profit Q3 2025 · Sep 30, 2025 $451.93K
Gross Profit Q3 2025 · Sep 30, 2025 $1.23M
Gross Profit Q3 2025 · Sep 30, 2024 $354.06K
Gross Profit Q3 2025 · Sep 30, 2024 $1.03M
Cost Of Revenue Q3 2025 · Sep 30, 2025 $61.86K
Cost Of Revenue Q3 2025 · Sep 30, 2025 $220.79K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $36.8K
Cost Of Revenue Q3 2025 · Sep 30, 2024 $108.97K
Revenue Q3 2025 · Sep 30, 2025 $513.79K
Revenue Q3 2025 · Sep 30, 2025 $1.45M
Revenue Q3 2025 · Sep 30, 2024 $390.85K
Revenue Q3 2025 · Sep 30, 2024 $1.13M